{
    "nctId": "NCT04902937",
    "briefTitle": "Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.",
    "officialTitle": "Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.",
    "overallStatus": "RECRUITING",
    "conditions": "Tumor Cell, Circulating",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Age-dependent influence of radiotherapy on circulating epithelial tumor cell counts (CETC) and immunophenotype (PBMC).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Primary diagnosis histologically confirmed invasive breast carcinoma pT1-4 pN0 or pN+ cM0\n* curative-intended breast-conserving therapy (BET) \u00b1 (neo-) adj. system therapy with subsequent adjuvant radiotherapy of the breast \u00b1 lymphatic drainage system planned\n* informed consent of the patient\n\nExclusion Criteria:\n\n* DCIS, Inflammatory breast carcinoma\n* Recurrence situation\n* Presence of distant metastases\n* Second malignancies \\< 10 years prior to diagnosis of breast carcinoma\n* Prior exposure to radiotherapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}